CMS(00867.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 986.1 million, YoY increase of 4.77%

NewTimeSpace News: August 17, 2026, CMS(00867.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 4.5 billion, increased by 12.46% YoY; Net Profit stood at CNY 971.48 million, YoY increase of 4.29%; Profit Attributable to Shareholders stood at CNY 986.1 million, YoY increase of 4.77%; Basic Earnings Per Share (EPS) stood at CNY 0.41.

In terms of profitability, CMS Gross Profit changed from CNY 2.89 billion in the same period last year to CNY 3.22 billion in the current period, increased by CNY 328.65 million; gross profit margin changed from 72.26% in the same period last year to 71.56% in the current period, decreased by 0.71 percentage points; net profit changed from CNY 931.49 million in the same period last year to CNY 971.48 million in the current period, increased by CNY 39.99 million; net profit margin changed from 23.28% in the same period last year to 21.59% in the current period, decreased by 1.69 percentage points.

In terms of earnings quality, CMS Operating Profit changed from CNY 989.95 million in the same period last year to CNY 1.03 billion in the current period, increased by CNY 41.49 million; Operating Profit Margin changed from 24.74% in the same period last year to 22.92% in the current period, decreased by 1.82 percentage points.

In terms of financial soundness, CMS Debt-to-Asset Ratio changed from 9.35% in the same period last year to 8.1% in the current period, decreased by 1.26 percentage points; Total Equity changed from CNY 17.166 billion in the same period last year to CNY 18.079 billion in the current period, increased by CNY 913.65 million; Current Liabilities changed from CNY 1.61 billion in the same period last year to CNY 1.4 billion in the current period, decreased by CNY 212.61 million; Quick Ratio changed from 5.28 in the same period last year to 5.97 in the current period, increased by 0.69 percentage points.

In terms of R&D investment focus, CMS R&D Expenses changed from CNY 202.49 million in the same period last year to CNY 356.68 million in the current period, increased by CNY 154.19 million; R&D to Total Revenue Ratio changed from 5.06% in the same period last year to 7.92% in the current period, increased by 2.86 percentage points.

By the close of trading on August 17, 2026, CMS(00867) saw a loss of 0.42% in its share price, closing at HKD 11.77. The full-day turnover stood at HKD 37.65 million, with the latest market capitalization at HKD 28.64 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.